focus -WSS

focus

author：comprehensive 2025-09-06 03:28:00 - browse：9

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Victims of gun violence feel impacts long after bullet wound

leisure time

WSS

More doctors should go into startup world

Medicare solvency divides Republicans at the presidential debate

Medicare solvency divides Republicans at the presidential debate

The new shift in health care is toward less care

Diversify hospital leadership teams to protect BIPOC patient health

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

hotspot

focus

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Extreme heat events are a public health emergency

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Dobbs anniversary: the lost opportunity of abortion as health care

UCSF medical school apologizes for unethical prisoner experiments

Walensky prepares to leave CDC — and Congress — behind

Study: New antibiotic targets gonorrhea as well as last existing drug

Duchenne breakthrough therapy leaves behind pioneering families

Senate panel clears PBM, hopsital reforms

leisure time

Will General Catalyst be the first of many hospital takeovers?

Just how powerful is the placebo effect?

HPV cancer vaccine study demonstrates efficacy

Medicare will require more price transparency from hospitals

More doctors should go into startup world

Just how powerful is the placebo effect?

leisure time

explore

entertainment

leisure time